Recent Company News

• 06:02 AM ET Aug 21, 2025
  

  BeOne Medicines announces that the European Commission has approved a new film-coated tablet formulation of BRUKINSA (zanubrutinib) for all approved indications ($309.33, 0.00)

• 10:26 AM ET Aug 18, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (89 total)

• 03:31 AM ET Aug 18, 2025
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (54 total)

• 12:23 AM ET Aug 18, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (170 total)

• 10:10 AM ET Aug 15, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (97 total)

• 03:44 AM ET Aug 15, 2025
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (37 total)

• 11:24 PM ET Aug 14, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (166 total)

• 02:59 AM ET Aug 12, 2025
  

  China announces the preliminary new commercial health insurance drug list; 121 out of 141 products passed initial screening

• 11:33 PM ET Aug 07, 2025
  

  StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning

• 04:35 PM ET Aug 06, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market